The dopaminergic dilema: Sleep or wake? Implications in Parkinson's disease

Bioscience Hypotheses

Volumn 1, Issue 1, 2008, Pages 9-13

  Lima, Marcelo M S ^a   Reksidler, Angela B ^a   Vital, Maria A B F ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Dopamine; REM sleep; Sleep; Sleep regulation; Substantia nigra

Indexed keywords

AMPHETAMINE; ANTIPARKINSON AGENT; DOPAMINE 2 RECEPTOR; MODAFINIL;

ARTICLE; DAYTIME SOMNOLENCE; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DRUG TARGETING; EVIDENCE BASED PRACTICE; HUMAN; HYPOTHESIS; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTOR CONTROL; NERVE CELL NETWORK; NEUROTRANSMISSION; PARKINSON DISEASE; REM SLEEP; SEROTONINERGIC SYSTEM; SLEEP PATTERN; SLEEP WAKING CYCLE; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 48549092028     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2008.01.010     Document Type: Article

References (43)

1. Abbott R.D., Ross G.W., White L.R., Tanner C.M., Masaki K.H., Nelson J.S., et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65 9 (2005) 1442-1446
2. Adler C.H. Nonmotor complications in Parkinson's disease. Mov Disord 20 Suppl. 11 (2005) S23-S29
3. Andrade L.A., Lima J.G., Tufik S., Bertolucci P.H., and Carlini E.A. REM sleep deprivation in an experimental model of Parkinson's disease. Arq Neuropsiquiatr 45 3 (1987) 217-223
4. Aserinsky E., and Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 118 (1953) 273-274
5. Braak H., Rub U., Gai W.P., and Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110 5 (2003) 517-536
6. Carlini E.A. REM sleep deprivation and dopamine in the CNS. Rev Pure Appl Pharmacol Sci 4 1 (1983) 1-25
7. Dahan L., Astier B., Vautrelle N., Urbain N., Kocsis B., and Chouvet G. Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology 32 6 (2007) 1232-1241
8. De Cock V.C., Vidailhet M., Leu S., Texeira A., Apartis E., Elbaz A., et al. Restoration of normal motor control in Parkinson's disease during REM sleep. Brain 130 Pt 2 (2007) 450-456
9. Del Tredici K., Rub U., De Vos R.A., Bohl J.R., and Braak H. Where does Parkinson disease pathology begin in the brain?. J Neuropathol Exp Neurol 61 5 (2002) 413-426
10. Dopheide M.M., Morgan R.E., Rodvelt K.R., Schachtman T.R., and Miller D.K. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants. Eur J Pharmacol (2007)
11. Dzirasa K., Ribeiro S., Costa R., Santos L.M., Lin S.C., Grosmark A., et al. Dopaminergic control of sleep-wake states. J Neurosci 26 41 (2006) 10577-10589
12. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 991 (2003) 1-14
13. Gagnon J.F., Bedard M.A., Fantini M.L., Petit D., Panisset M., Rompre S., et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 59 4 (2002) 585-589
14. Happe S., Baier P.C., Helmschmied K., Meller J., Tatsch K., and Paulus W. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease. J Neurol (2007)
15. Hogl B., Saletu M., Brandauer E., Glatzl S., Frauscher B., Seppi K., et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 25 8 (2002) 905-909
16. Jones B.E. Arousal systems. Front Biosci 8 (2003) s438-s451
17. Lima M.M.S., Andersen M.L., Reksidler A.B., Silva A., Zager A., Zanata S.M., et al. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation. Behav Brain Res 188 (2008) 406-411
18. Lima M.M.S., Andersen M.L., Reksidler A.B., Vital M.A.B.F., and Tufik S. The role of the substantia nigra pars compacta in regulating sleep patterns in rats. PLoS ONE 2 (2007) e513
19. Lima M.M.S., Braga Reksidler A., Marques Zanata S., Bueno Machado H., Tufik S., and Vital M.A. Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. Brain Res 1101 1 (2006) 117-125
20. Maloney K.J., Mainville L., and Jones B.E. c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery. Eur J Neurosci 15 4 (2002) 774-778
21. McCarley R.W. Neurobiology of REM and NREM sleep. Sleep Med 8 4 (2007) 302-330
22. Minzenberg M.J., and Carter C.S. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology (2007)
23. Monti J.M. Catecholamines and the sleep-wake cycle. I. EEG and behavioral arousal. Life Sci 30 14 (1982) 1145-1157
24. Monti J.M., and Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 11 2 (2007) 113-133
25. Murillo-Rodriguez E., Haro R., Palomero-Rivero M., Millan-Aldaco D., and Drucker-Colin R. Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav Brain Res 176 2 (2007) 353-357
26. 2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res Bull 34 5 (1994) 453-456
27. Porkka-Heiskanen T., Tuomisto L., Ylinen M., and Stenberg D. The effect of REM sleep deprivation on histamine concentrations in different brain areas. Life Sci 54 22 (1994) 1719-1726
28. Portas C.M., Bjorvatn B., and Ursin R. Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Prog Neurobiol 60 1 (2000) 13-35
29. Reksidler A.B., Lima M.M.S., Dombrowski P., Andersen M.L., Zanata S.M., Andreatini R., et al. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease. J Neurosci Methods 167 2 (2008) 268-277
30. Reksidler A.B., Lima M.M.S., Zanata S.M., Machado H.B., da Cunha C., Andreatini R., et al. The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats. Eur J Pharmacol 560 2-3 (2007) 163-175
31. Rye D.B. The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 63 8 Suppl. 3 (2004) S2-S7
32. Rye D.B. Excessive daytime sleepiness and unintended sleep in Parkinson's disease. Curr Neurol Neurosci Rep 6 2 (2006) 169-176
33. Sandyk R. Treatment with weak electromagnetic fields restores dream recall in a parkinsonian patient. Int J Neurosci 90 1-2 (1997) 75-86
34. Saper C.B., Scammell T.E., and Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 437 7063 (2005) 1257-1263
35. Siegel J.M. Hypocretin (orexin): role in normal behavior and neuropathology. Annu Rev Psychol 55 (2004) 125-148
36. Solms M. Dreaming and REM sleep are controlled by different brain mechanisms. Behav Brain Sci 23 6 (2000) 843-850 discussion 904-1121
37. Steininger T.L., Alam M.N., Gong H., Szymusiak R., and McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 840 1-2 (1999) 138-147
38. Steriade M., Amzica F., and Nunez A. Cholinergic and noradrenergic modulation of the slow (approximately 0.3 Hz) oscillation in neocortical cells. J Neurophysiol 70 4 (1993) 1385-1400
39. Stickgold R., and Walker M.P. Sleep-dependent memory consolidation and reconsolidation. Sleep Med 8 4 (2007) 331-343
40. Tufik S. Increased responsiveness to apomorphine after REM sleep deprivation: supersensitivity of dopamine receptors or increase in dopamine turnover?. J Pharm Pharmacol 33 11 (1981) 732-738
41. Tufik S., Lindsey C.J., and Carlini E.A. Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?. Pharmacology 16 2 (1978) 98-105
42. Walker M.P., Brakefield T., Hobson J.A., and Stickgold R. Dissociable stages of human memory consolidation and reconsolidation. Nature 425 6958 (2003) 616-620
43. Walker M.P., and Stickgold R. Sleep-dependent learning and memory consolidation. Neuron 44 1 (2004) 121-133